CN Patent

CN101595107A — 能提高p53活性的有取代哌啶及其用途

Assigned to Merck Sharp and Dohme LLC · Expires 2009-12-02 · 16y expired

What this patent protects

在其许多实施方案中，本发明揭示作为HDM2蛋白的抑制剂的新颖化合物；制备此类化合物的方法；包括一或多种此类化合物的医药组合物；使用此类化合物或医药组合物治疗、预防、抑制一种或多种与HDM2蛋白或P53相关的疾病的方法。

USPTO Abstract

在其许多实施方案中，本发明揭示作为HDM2蛋白的抑制剂的新颖化合物；制备此类化合物的方法；包括一或多种此类化合物的医药组合物；使用此类化合物或医药组合物治疗、预防、抑制一种或多种与HDM2蛋白或P53相关的疾病的方法。

Drugs covered by this patent

Patent Metadata

Patent number: CN101595107A
Jurisdiction: CN
Classification: —
Expires: 2009-12-02
Drug substance claim: No
Drug product claim: No
Assignee: Merck Sharp and Dohme LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.